Drug profile · INN
pentostatin
NIPENT
pentostatin (NIPENT) is a adenosine deaminase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — pentostatin
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pentostatin (NIPENT) is a adenosine deaminase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adenosine deaminase inhibitor
Primary target: Adenosine deaminase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is pentostatin?
pentostatin (NIPENT) is a adenosine deaminase inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pentostatin?
NIPENT is a marketed brand name for pentostatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pentostatin?
pentostatin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.